SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant market volatility following a launch setback where its latest satellite was deployed into an unsustainable orbit, forcing it to be de-orbited. While the company maintains that insurance will cover the loss and that production schedules remain intact, the community is actively debating the reliability of launch partners, the impact on future constellation deployment timelines, and whether this represents a temporary execution hiccup or a more serious fundamental risk.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors debate the potential Phase 3 data for its lead oncology asset, GPS, while closely watching the upcoming AACR conference for disclosures on SLS009. The community remains deeply divided, with bulls highlighting successful clinical milestones and a potential buyout opportunity, while bears voice significant concerns regarding trial design, dosing modifications, and long-term financial viability.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is experiencing significant market attention as a strategic partner to NVIDIA for quantum calibration and decoding, fueling a broader community narrative that the stock is currently mispriced compared to its peers. Investors are actively discussing the high-beta nature of the stock, analyzing the potential impacts of share unlock provisions, and debating its long-term potential as a key player in the quantum sensing and defense sectors.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently in the spotlight due to its strategic acquisition of Mynaric, which significantly bolsters its vertical integration in optical communications and reinforces its role as a full-stack space infrastructure provider. The community remains highly engaged with the stock's growth trajectory, frequently highlighting progress on the Neutron launch vehicle, defense contract wins, and the anticipated market tailwinds from a potential SpaceX IPO.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is drawing significant investor attention as analysts upgrade price targets, citing accelerating AI infrastructure demand and potential long-term benefits from custom silicon and optical networking partnerships. The community remains actively focused on Marvell's role in scaling hyperscale AI capacity, with many retail bulls highlighting the company's technical breakout as a signal of sustained momentum.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing a surge in market activity driven by the U.S. government's executive order to fast-track research and regulatory review of psychedelic-based therapies. The stock is a primary focus for community members who are actively debating its potential for National Priority Vouchers, upcoming phase 3 trial results, and broader institutional re-rating as the psychedelic biotech sector gains significant policy tailwinds.

Vanguard World Fund - Vanguard Information Technology ETF

Vanguard Information Technology ETF

Vanguard Information Technology ETF is seeing a surge in community interest as investors discuss its long-term growth potential and strong historical returns. Many are actively debating whether to accumulate shares during market volatility or wait for further pullbacks while highlighting the fund's efficiency and diversification compared to individual tech stocks.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is currently drawing significant attention from investors who view the stock as a compelling turnaround play following years of underperformance, with recent price action testing critical resistance levels. The community is actively debating the stock's stability, weighing a strong dividend yield and operational restructuring efforts against concerns over persistent shipping volume declines and rising fuel costs.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

The Aircoin community is rallying behind the token's unique PvE (Player vs. Everyone) narrative, high holder retention, and significant on-chain supply locking via its 'AirLock' mechanism. Investors are increasingly viewing it as a long-term conviction play on Solana, highlighting its transparent, community-led treasury and organic growth as key differentiators from hype-driven memecoins.

ETF Opportunities Trust - T-Rex 2X Inverse MSTR Daily Target ETF

T-Rex 2X Inverse MSTR Daily Target ETF

The T-Rex 2X Inverse MSTR Daily Target ETF is seeing high activity as traders aggressively play the volatility of MicroStrategy, with the community actively debating whether to capitalize on downward swings or hedge against broader crypto market corrections. Sentiment remains polarized between those utilizing the inverse instrument for tactical scalps and those holding core positions while monitoring Bitcoin price action as a key indicator for potential reversals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Corcept 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

Kahn Swick & Foti, LLC (KSF) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 21, 2026 to file lead plaintiff applications...

CORT SHAREHOLDER ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss

CORT SHAREHOLDER ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss CORT SHAREHOLDER ALERT: Hagens...

Corcept Deadline: CORT Investors with Losses in Excess of $100K Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit

Corcept Deadline: CORT Investors with Losses in Excess of $100K Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit Corcept Deadline: CORT Investors with Losses in...

Deadline Soon: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz reminds investors of the upcoming April 21, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT INVESTOR ALERT...

INVESTOR NOTICE: Corcept Therapeutics (CORT) Investors with Substantial Losses Have Opportunity to Lead the Investor Class Action - Hagens Berman

INVESTOR NOTICE: Corcept Therapeutics (CORT) Investors with Substantial Losses Have Opportunity to Lead the Investor Class Action - Hagens Berman INVESTOR NOTICE: Corcept Therapeutics (CORT...

Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have...

CORT Shareholder Alert: Corcept Therapeutics Incorporated Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm

CORT Shareholder Alert: Corcept Therapeutics Incorporated Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm CORT Shareholder Alert: Corcept Therapeutics...

CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure

CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure CORT ALERT: Hagens...

Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT

Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT Corcept Therapeutics Incorporated Sued for Securities Law Violations...

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.11	--	--	N/A
Q4 '25	$0.33	$0.20	-39.30%	MISSED
Q3 '25	$0.13	$0.16	18.98%	BEAT
Q2 '25	$0.19	$0.29	54.67%	BEAT
Q1 '25	$0.14	$0.17	19.30%	BEAT

CORT
Corcept Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest CORT News

CORTCorcept Therapeutics Inc